By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biovail Laboratories Inc. 

Chelston Park, Building 2, Ground Floor
Collymore Rock
St. Michael  Barbados    West Indies
Phone: 246-437-7080 Fax: 246-437-7085



Company News
Cortex Pharmaceuticals, Inc. (COR) Reacquires all AMPAKINE(R) Compounds, Related Patents and Exclusive Global Rights for Respiratory Depression from Biovail Laboratories Inc. 3/16/2011 6:57:55 AM
Valeant Pharmaceuticals International (VRX) Announces License Of ACZONE(R) (dapsone) Gel 5% In Canada by Biovail Laboratories Inc. From Allergan Inc. (AGN) 2/8/2011 7:19:39 AM
ACADIA Pharmaceuticals, Inc. (ACAD) Enters Agreement with Biovail Laboratories Inc. to Conclude Collaboration and Regain North American Rights to Pimavanserin; Acadia Receives $8.75 Million 10/28/2010 6:21:58 AM
Biovail Laboratories Inc. Merger with Valeant Pharmaceuticals International (VRX) to Prompt 15-20% Headcount Cut 6/22/2010 8:12:30 AM
Alexza Pharmaceuticals, Inc. (ALXA) Inks Deal with Biovail Laboratories Inc. for Anti-Psychotic Drug; Alexza to Get $40 Million Upfront 2/10/2010 6:59:27 AM
MedGenesis Therapeutix Announces Agreements With Amgen (AMGN) (JOBS) and Biovail Laboratories Inc. 1/12/2010 7:06:11 AM
Flamel Technologies (FLML) Announces Termination Of Licensing Agreement With Biovail Laboratories Inc. For Genvir And Recovery Of Rights10/19/2005 5:12:55 PM